RhumbLine Advisers’s CryoPort CYRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.21M | Buy |
77,102
+1,137
| +1% | +$14.6K | ﹤0.01% | 2199 |
|
|
2026
Q1 | $629K | Sell |
75,965
-2,728
| -3% | -$24.6K | ﹤0.01% | 2468 |
|
|
2025
Q4 | $755K | Sell |
78,693
-12,748
| -14% | -$120K | ﹤0.01% | 2386 |
|
|
2025
Q3 | $867K | Sell |
91,441
-657
| -0.7% | -$5.53K | ﹤0.01% | 2324 |
|
|
2025
Q2 | $687K | Buy |
92,098
+13,778
| +18% | +$85.5K | ﹤0.01% | 2458 |
|
|
2025
Q1 | $476K | Buy |
78,320
+15,036
| +24% | +$104K | ﹤0.01% | 2605 |
|
|
2024
Q4 | $492K | Buy |
63,284
+1,764
| +3% | +$13.2K | ﹤0.01% | 2689 |
|
|
2024
Q3 | $499K | Sell |
61,520
-2,638
| -4% | -$21.6K | ﹤0.01% | 2699 |
|
|
2024
Q2 | $443K | Buy |
64,158
+2,086
| +3% | +$28.1K | ﹤0.01% | 2767 |
|
|
2024
Q1 | $1.1M | Buy |
62,072
+1,888
| +3% | +$29.9K | ﹤0.01% | 2204 |
|
|
2023
Q4 | $932K | Sell |
60,184
-35
| -0.1% | -$457 | ﹤0.01% | 2296 |
|
|
2023
Q3 | $826K | Sell |
60,219
-15,728
| -21% | -$232K | ﹤0.01% | 2316 |
|
|
2023
Q2 | $1.31M | Buy |
75,947
+14,498
| +24% | +$297K | ﹤0.01% | 2155 |
|
|
2023
Q1 | $1.48M | Buy |
61,449
+1,826
| +3% | +$39.7K | ﹤0.01% | 1965 |
|
|
2022
Q4 | $1.03M | Buy |
59,623
+563
| +1% | +$11.9K | ﹤0.01% | 2110 |
|
|
2022
Q3 | $1.44M | Buy |
59,060
+3,835
| +7% | +$132K | ﹤0.01% | 1949 |
|
|
2022
Q2 | $1.71M | Buy |
55,225
+12,357
| +29% | +$329K | ﹤0.01% | 1838 |
|
|
2022
Q1 | $1.5M | Buy |
42,868
+357
| +0.8% | +$13.5K | ﹤0.01% | 1954 |
|
|
2021
Q4 | $2.52M | Sell |
42,511
-171
| -0.4% | -$11.8K | ﹤0.01% | 1752 |
|
|
2021
Q3 | $2.84M | Buy |
42,682
+1,630
| +4% | +$101K | ﹤0.01% | 1693 |
|
|
2021
Q2 | $2.59M | Sell |
41,052
-394
| -1% | -$22.2K | ﹤0.01% | 1817 |
|
|
2021
Q1 | $2.16M | Sell |
41,446
-510
| -1% | -$31K | ﹤0.01% | 1874 |
|
|
2020
Q4 | $1.84M | Buy |
41,956
+1,377
| +3% | +$65.6K | ﹤0.01% | 1888 |
|
|
2020
Q3 | $1.92M | Sell |
40,579
-7,936
| -16% | -$321K | ﹤0.01% | 1704 |
|
|
2020
Q2 | $1.47M | Buy |
48,515
+8,509
| +21% | +$189K | ﹤0.01% | 1886 |
|
|
2020
Q1 | $683K | Buy |
40,006
+190
| +0.5% | +$3.33K | ﹤0.01% | 2036 |
|
|
2019
Q4 | $655K | Buy |
39,816
+1,273
| +3% | +$18.9K | ﹤0.01% | 2251 |
|
|
2019
Q3 | $630K | Buy |
38,543
+2,310
| +6% | +$46.3K | ﹤0.01% | 2239 |
|
|
2019
Q2 | $664K | Buy |
36,233
+1,271
| +4% | +$20.2K | ﹤0.01% | 2249 |
|
|
2019
Q1 | $452K | Buy |
34,962
+1,043
| +3% | +$11.3K | ﹤0.01% | 2369 |
|
|
2018
Q4 | $374K | Buy |
33,919
+11,321
| +50% | +$123K | ﹤0.01% | 2431 |
|
|
2018
Q3 | $289K | Sell |
22,598
-1,169
| -5% | -$16.7K | ﹤0.01% | 2532 |
|
|
2018
Q2 | $375K | Buy |
+23,767
| New | +$253K | ﹤0.01% | 2436 |
|
Other funds holding CYRX
CCM
FAM
MCO
RhumbLine Advisers's CYRX Position: Q2 2026 in Review
RhumbLine Advisers increased its CryoPort (CYRX) stake by 1.5% in Q2 2026, buying an estimated $14.6K and bringing the position to 77,102 shares worth $1.21M. The position accounts for ﹤0.01% of the portfolio, ranked #2199.
RhumbLine Advisers first reported a position in CYRX in Q2 2018 and has held it in 33 quarters since. The position peaked at $2.84M in Q3 2021. 185 funds tracked by Wall St. Rank hold CYRX as of Q2 2026.
- RhumbLine Advisers held 77,102 shares of CryoPort worth $1.21M as of Q2 2026.
- RhumbLine Advisers bought 1,137 CryoPort shares in Q2 2026, an estimated $14.6K.
- CryoPort made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #2199 holding.
- RhumbLine Advisers first reported a position in CryoPort in Q2 2018 and has held it in 33 quarters since.
- RhumbLine Advisers's CryoPort position peaked at $2.84M in Q3 2021.
- 185 funds tracked by Wall St. Rank held CryoPort as of Q2 2026.
Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.